Achieve Life Sciences shareholders approve authorized common stock increase to 300 million shares at annual meeting

Achieve Life Sciences, Inc.

Achieve Life Sciences, Inc.

ACHV

0.00

  • Achieve Life Sciences held its annual stockholder meeting on July 2, 2026.
  • Stockholders ratified PricewaterhouseCoopers LLP as independent registered public accounting firm for the fiscal year ending Dec. 31, 2026.
  • Stockholders authorized an amendment to the certificate of incorporation to raise authorized common shares to 300,000,000 from 150,000,000.
  • The charter amendment was executed on July 6, 2026, when a certificate of amendment was filed.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Achieve Life Sciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-296174), on July 06, 2026, and is solely responsible for the information contained therein.